As of 2025-10-18, the Relative Valuation of Cara Therapeutics Inc (CARA) is (263.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -5055.2%.
The range of the Relative Valuation is (256.18) - (290.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 18.8x | 16.2x |
| Forward P/E multiples | 16.5x - 19.3x | 17.8x |
| Fair Price | (256.18) - (290.91) | (263.62) |
| Upside | -4915.3% - -5568.3% | -5055.2% |
| Date | P/E |